Table 2-4 Patients’ background 4.
| a. Total | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Malignant neoplasm | Sites of malignant neoplasm | ||||||||||||||
| (−) | (+) | Head and neck | Esophagus | Lung | Stomach | Hepatobiliary pancreas | Colon | Breast | Uterus | Ovarium | Prostate | Others | |||
| History of cancer | Under treatment* | Unknown | |||||||||||||
| Rutherford 4 | 212 | 20 | 9 | 0 | 2 | 0 | 3 | 2 | 6 | 6 | 2 | 2 | 0 | 2 | 9 |
| Rutherford 5 | 668 | 41 | 13 | 5 | 5 | 0 | 13 | 13 | 2 | 15 | 2 | 0 | 0 | 0 | 8 |
| Rutherford 6 | 157 | 8 | 4 | 1 | 1 | 1 | 1 | 4 | 0 | 2 | 0 | 1 | 0 | 1 | 3 |
| Total | 1,037 | 69 | 26 | 6 | 8 | 1 | 17 | 19 | 8 | 23 | 4 | 3 | 0 | 3 | 20 |
| b. ASO | |||||||||||||||
| Malignant neoplasm | Sites of malignant neoplasm | ||||||||||||||
| (−) | (+) | Head and neck | Esophagus | Lung | Stomach | Hepatobiliary pancreas | Colon | East | Uterus | Ovarium | Prostate | Others | |||
| History of cancer | Under treatment* | Unknown | |||||||||||||
| Rutherford 4 | 207 | 20 | 9 | 0 | 2 | 0 | 3 | 2 | 6 | 6 | 2 | 2 | 0 | 2 | 9 |
| Rutherford 5 | 651 | 41 | 13 | 5 | 5 | 0 | 13 | 13 | 2 | 15 | 2 | 0 | 0 | 0 | 8 |
| Rutherford 6 | 155 | 8 | 4 | 1 | 1 | 1 | 1 | 4 | 0 | 2 | 0 | 1 | 0 | 1 | 3 |
| Total | 1,013 | 69 | 26 | 6 | 8 | 1 | 17 | 19 | 8 | 23 | 4 | 3 | 0 | 3 | 20 |
* Including palliative therapy or recurrence.